Research Options:

Week of Expected Pricing 10/29/2024
Company Name GELTEQ LTD
Proposed Ticker GELS
CUSIP Q3978B109
Business Description We are a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. A “white label” gel-based delivery solution is where we produce a product that other companies rebrand as their own product. Our principal products are edible gels, which we refer to as gels, and their application in gel-based dosage forms. Our current product suite consists of multiple products that sit within five core verticals — for pets, sports,pharmaceutical (pharma), over-the-counter (OTC) and nutraceutical — all of which leverage our patent pending multiple-ingredient dosage forms, and that we expect to have a wide range of applications and consumers. We currently focus our efforts on out-licensing our technology to companies to develop and create new products they can manufacture and sell within their established and researched markets, while we continue to manufacture our existing products under license.
Lead Underwriter The Benchmark Company, LLC
Co-Managers N/A
Initial Shares 1,300,000
Revised Initial Shares N/A
Initial Price $5.00-$5.00
Revised Price $4.00-$4.00
Final Price $4.00
Final Ticker GELS

 

 

   
  © 2024 ICE Data Services. All rights reserved.